- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股处于空头行情中，可能有短期反弹。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有175家主力机构披露2025-06-30报告期持股数据，持仓量总计1.34亿股，占流通A股10.94%
- 波段诊断：
-
技术面诊股
诊断结果：5.8技术面打败了42%的股票
技术面评分前10的股票
近期的平均成本为10.04元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为10.04元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"10.04","date":1763626331,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2025.11.21","stock":"-4.17","trade":"-3.82","ind":"-3.41"},{"date":"2025.11.20","stock":"-1.25","trade":"-0.92","ind":"-0.76"},{"date":"2025.11.19","stock":"0.00","trade":"-1.90","ind":"-0.00"},{"date":"2025.11.18","stock":"-1.32","trade":"-0.92","ind":"-0.92"},{"date":"2025.11.17","stock":"-2.40","trade":"-2.18","ind":"-0.11"},{"date":"2025.11.14","stock":"-1.72","trade":"0.63","ind":"-1.93"},{"date":"2025.11.13","stock":"-0.90","trade":"1.09","ind":"1.78"},{"date":"2025.11.12","stock":"-0.36","trade":"0.87","ind":"-0.36"},{"date":"2025.11.11","stock":"-0.62","trade":"0.43","ind":"-1.03"},{"date":"2025.11.10","stock":"2.74","trade":"1.72","ind":"0.18"},{"date":"2025.11.07","stock":"2.25","trade":"-0.48","ind":"-0.36"},{"date":"2025.11.06","stock":"-0.74","trade":"-0.33","ind":"1.73"},{"date":"2025.11.05","stock":"-0.65","trade":"-0.81","ind":"0.37"},{"date":"2025.11.04","stock":"-0.55","trade":"-0.81","ind":"-1.71"},{"date":"2025.11.03","stock":"-0.09","trade":"0.04","ind":"0.19"},{"date":"2025.10.31","stock":"6.75","trade":"4.09","ind":"-1.14"},{"date":"2025.10.30","stock":"-0.97","trade":"-0.83","ind":"-1.16"},{"date":"2025.10.29","stock":"0.88","trade":"1.00","ind":"1.95"},{"date":"2025.10.28","stock":"0.29","trade":"0.24","ind":"-0.44"},{"date":"2025.10.27","stock":"1.29","trade":"0.61","ind":"1.51"},{"date":"2025.10.24","stock":"-0.30","trade":"0.39","ind":"2.02"}]
安科生物,深证成指,生物制品指数
压力支撑
该股压力位为10.04元，支撑位为9.73元。
[{"text":"\u538b\u529b\u4f4d","value":"10.04","date":1763654400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"9.73","date":1763654400,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.4资金面打败了1%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：11月21日 20:30
| 机构今日流向(万元) | -2158.17 | 机构5日流向(万元) | -10939.34 |
| 机构10日流向(万元) | -11671.27 | 机构20日流向(万元) | -15749.33 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少2009.38万股，其中基金净减仓19家，主力净减仓1家，请投资者中长期谨慎为宜。
截止2025-06-30，共175家主力机构（基金173家，一般法人2家），持仓量总计13369万股，占流通A股10.94%
其中，基金持仓与2024-12-31相比：
增仓：21家 ，增持 64.45万股
减仓：40家 ，减持 665.35万股
新出现在主力名单中：110家 ，持有5562.42万股
从主力名单中消失：111家 ，原持有7701.51万股
其中，基金持仓与2024-12-31相比：
增仓：21家 ，增持 64.45万股
减仓：40家 ，减持 665.35万股
新出现在主力名单中：110家 ，持有5562.42万股
从主力名单中消失：111家 ，原持有7701.51万股
消息面诊股
诊断结果：5.5消息面打败了27%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 行业周报|生物制品指数跌-9.39%, 跑输上证指
2025-11-21 - 海归博士卖房在苏州创业，又获3000万战略投资
2025-11-21 - 安科生物（截止2025年11月10日）股东人数为7
2025-11-20 - 安科生物：隆培促生长素处于正常审评中
2025-11-20 - 安科生物：三季度公司实现营业收入、净利润的双增长，
2025-11-20 - 安科生物：博生吉的CD7-CAR-T待产品获批后计
2025-11-20 - 安科生物：搭建国内领先、自主创新的调节T细胞中试培
2025-11-20 - 安科生物：公司代理的长效促卵泡素已于11月初正式发
2025-11-20 - 【华安医药】公司点评安科生物：25Q3业绩增长，参
2025-11-19 - 上周公募基金调研132只个股逾700次 工业富联成
2025-11-17
消息列表
| 一般消息 | 募资投向 | 公司购买资产 | 2025-11-11 |
| 一般消息 | 重大事项 | 关联交易 | 2025-11-11 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-22 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-07-11 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 利好 | 分红转增 | 10派1.5元(含税) | 2025-03-28 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 利好 | 分红转增 | 10派1元(含税) | 2024-12-20 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.2行业面打败了86%的股票
生物制品行业最新资金流向
近10日来该行业走势总体向下，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，接近大盘。
[{"date":"2025.11.21","price":"-3.41","value":"-3.82"},{"date":"2025.11.20","price":"-0.76","value":"-0.92"},{"date":"2025.11.19","price":"-0.00","value":"-1.90"},{"date":"2025.11.18","price":"-0.92","value":"-0.92"},{"date":"2025.11.17","price":"-0.11","value":"-2.18"},{"date":"2025.11.14","price":"-1.93","value":"0.63"},{"date":"2025.11.13","price":"1.78","value":"1.09"},{"date":"2025.11.12","price":"-0.36","value":"0.87"},{"date":"2025.11.11","price":"-1.03","value":"0.43"},{"date":"2025.11.10","price":"0.18","value":"1.72"},{"date":"2025.11.07","price":"-0.36","value":"-0.48"},{"date":"2025.11.06","price":"1.73","value":"-0.33"},{"date":"2025.11.05","price":"0.37","value":"-0.81"},{"date":"2025.11.04","price":"-1.71","value":"-0.81"},{"date":"2025.11.03","price":"0.19","value":"0.04"},{"date":"2025.10.31","price":"-1.14","value":"4.09"},{"date":"2025.10.30","price":"-1.16","value":"-0.83"},{"date":"2025.10.29","price":"1.95","value":"1.00"},{"date":"2025.10.28","price":"-0.44","value":"0.24"},{"date":"2025.10.27","price":"1.51","value":"0.61"},{"date":"2025.10.24","price":"2.02","value":"0.39"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万泽股份 | 24.60% | -6.51% | 5.6分 |
| 2 | 金迪克 | 24.60% | -25.54% | 5.5分 |
| 3 | 三生国健 | 15.62% | -12.45% | 5.9分 |
| 4 | 博晖创新 | 14.43% | -15.64% | 5.5分 |
| 5 | 特宝生物 | 9.30% | 0.64% | 6.7分 |
| 6 | 康华生物 | 7.33% | -7.79% | 5.4分 |
| 8 | 华兰疫苗 | 5.51% | -16.27% | 5.3分 |
| 10 | ST未名 | 3.17% | -3.94% | 5.2分 |
| 12 | - | -1.08% | -16.67% | 分 |
| 14 | 优宁维 | -1.76% | -8.65% | 5.5分 |
| 16 | 安科生物 | -1.99% | -8.86% | 5.2分 |
| 18 | 东宝生物 | -2.50% | -8.70% | 5.5分 |
| 20 | 辽宁成大 | -3.11% | -7.87% | 5.4分 |
| 22 | - | -3.24% | -13.11% | 分 |
| 24 | 赛升药业 | -3.32% | -14.83% | 4.5分 |
| 26 | 赛伦生物 | -3.83% | -9.25% | 5.5分 |
| 28 | 荣昌生物 | -4.19% | -4.09% | 6.1分 |
| 30 | 华兰生物 | -4.50% | -7.96% | 5.4分 |
| 32 | 近岸蛋白 | -4.72% | -11.42% | 4.7分 |
| 34 | 君实生物 | -5.37% | -8.36% | 5.6分 |
| 36 | *ST四环 | -5.77% | -6.49% | 5.3分 |
| 38 | 义翘神州 | -6.62% | -11.24% | 5.2分 |
| 40 | 康弘药业 | -6.72% | -8.14% | 5.9分 |
| 42 | *ST双成 | -7.71% | -8.96% | 5.0分 |
| 44 | 西藏药业 | -7.79% | -12.22% | 5.6分 |
| 46 | 我武生物 | -8.84% | -10.85% | 5.5分 |
| 48 | 康希诺 | -10.40% | -11.03% | 5.2分 |
| 50 | 凯因科技 | -11.21% | -13.04% | 5.3分 |
| 52 | 甘李药业 | -11.93% | -9.86% | 5.5分 |
| 54 | 长春高新 | -16.06% | -5.39% | 5.4分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 5/72 ， 24/72。
[{"date":"2025-09-30","value":"13.30","vol":"-9.78"},{"date":"2025-06-30","value":"9.06","vol":"-0.61"},{"date":"2025-03-31","value":"5.09","vol":"0.46"},{"date":"2024-12-31","value":"17.98","vol":"-0.68"},{"date":"2024-09-30","value":"15.37","vol":"1.34"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
13.30 | 9.06 | 5.09 | 17.98 | 15.37 |
| 行业(%) | -9.78 | -0.61 | 0.46 | -0.68 | 1.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"75.97","vol":"67.61"},{"date":"2025-06-30","value":"76.45","vol":"68.28"},{"date":"2025-03-31","value":"76.96","vol":"68.43"},{"date":"2024-12-31","value":"77.39","vol":"69.85"},{"date":"2024-09-30","value":"77.75","vol":"70.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
75.97 | 76.45 | 76.96 | 77.39 | 77.75 |
| 行业(%) | 67.61 | 68.28 | 68.43 | 69.85 | 70.47 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 29/72 ， 28/72。
[{"date":"2025-09-30","value":"2.15","vol":"45.25"},{"date":"2025-06-30","value":"-0.51","vol":"6902.04"},{"date":"2025-03-31","value":"-4.17","vol":"6125.27"},{"date":"2024-12-31","value":"-11.51","vol":"47.35"},{"date":"2024-09-30","value":"-4.95","vol":"175.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
2.15 | -0.51 | -4.17 | -11.51 | -4.95 |
| 行业(%) | 45.25 | 6902.04 | 6125.27 | 47.35 | 175.00 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-6.48","vol":"44.80"},{"date":"2025-06-30","value":"-11.92","vol":"5.44"},{"date":"2025-03-31","value":"-4.02","vol":"-8.46"},{"date":"2024-12-31","value":"-16.56","vol":"-9.81"},{"date":"2024-09-30","value":"-9.89","vol":"-52.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-6.48 | -11.92 | -4.02 | -16.56 | -9.89 |
| 行业(%) | 44.80 | 5.44 | -8.46 | -9.81 | -52.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，居行业前列，两项指标的行业排名分别为 5/72 ， 6/72。
[{"date":"2025-09-30","value":"0.38","vol":"0.22"},{"date":"2025-06-30","value":"0.26","vol":"0.14"},{"date":"2025-03-31","value":"0.12","vol":"0.06"},{"date":"2024-12-31","value":"0.50","vol":"0.29"},{"date":"2024-09-30","value":"0.39","vol":"0.22"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.38 | 0.26 | 0.12 | 0.50 | 0.39 |
| 行业(次) | 0.22 | 0.14 | 0.06 | 0.29 | 0.22 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.64","vol":"0.92"},{"date":"2025-06-30","value":"1.05","vol":"0.56"},{"date":"2025-03-31","value":"0.49","vol":"0.26"},{"date":"2024-12-31","value":"2.15","vol":"1.17"},{"date":"2024-09-30","value":"1.58","vol":"0.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.64 | 1.05 | 0.49 | 2.15 | 1.58 |
| 行业(次) | 0.92 | 0.56 | 0.26 | 1.17 | 0.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"35.71","vol":"1.84"},{"date":"2025-06-30","value":"18.27","vol":"-1377.61"},{"date":"2025-03-31","value":"31.05","vol":"-46.99"},{"date":"2024-12-31","value":"43.02","vol":"-11.33"},{"date":"2024-09-30","value":"34.56","vol":"-30.88"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 35.71 | 18.27 | 31.05 | 43.02 | 34.56 |
| 行业 | 1.84 | -1377.61 | -46.99 | -11.33 | -30.88 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.52","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.94","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.52 | - | 0.94 | - |
| 行业 | 0.00 | 1.59 | 0.00 | 2.01 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 30/72 ， 32/72。
[{"date":"2025-09-30","value":"3.78","vol":"6.00"},{"date":"2025-06-30","value":"3.36","vol":"6.64"},{"date":"2025-03-31","value":"3.07","vol":"7.75"},{"date":"2024-12-31","value":"3.41","vol":"6.72"},{"date":"2024-09-30","value":"3.20","vol":"7.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.78 | 3.36 | 3.07 | 3.41 | 3.20 |
| 行业 | 6.00 | 6.64 | 7.75 | 6.72 | 7.02 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"3.05","vol":"4.84"},{"date":"2025-06-30","value":"2.63","vol":"5.30"},{"date":"2025-03-31","value":"2.61","vol":"6.35"},{"date":"2024-12-31","value":"2.95","vol":"5.40"},{"date":"2024-09-30","value":"2.70","vol":"5.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.05 | 2.63 | 2.61 | 2.95 | 2.70 |
| 行业 | 4.84 | 5.30 | 6.35 | 5.40 | 5.66 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 33/72 ， 33/72。
[{"date":"2025-09-30","value":"14.81","vol":"28.18"},{"date":"2025-06-30","value":"15.83","vol":"26.73"},{"date":"2025-03-31","value":"16.52","vol":"26.03"},{"date":"2024-12-31","value":"16.27","vol":"25.81"},{"date":"2024-09-30","value":"17.20","vol":"24.44"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
14.81 | 15.83 | 16.52 | 16.27 | 17.20 |
| 行业(%) | 28.18 | 26.73 | 26.03 | 25.81 | 24.44 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.18","vol":"0.58"},{"date":"2025-06-30","value":"0.20","vol":"1.11"},{"date":"2025-03-31","value":"0.21","vol":"0.78"},{"date":"2024-12-31","value":"0.20","vol":"0.87"},{"date":"2024-09-30","value":"0.22","vol":"0.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.18 | 0.20 | 0.21 | 0.20 | 0.22 |
| 行业(%) | 0.58 | 1.11 | 0.78 | 0.87 | 0.40 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 华安证券 | 2025-11-17 | 买入 | 买入 |
| 华鑫证券 | 2025-08-26 | 买入 | |
| 国金证券 | 2025-08-22 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"2.07","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"7.03","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"8.47","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"7.07","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"7.86","blueLineValue":"0.47","type":"YC"}]